Cleared Traditional

A&D Medical Blood Pressure Monitors (K173065) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K173065 · A&D Company, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
572d
Days
Class 2
Risk

K173065 is an FDA 510(k) clearance for the A&D Medical Blood Pressure Monitors. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by A&D Company, Ltd. (San Jose, US). The FDA issued a Cleared decision on April 24, 2019 after a review of 572 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all A&D Company, Ltd. devices

Submission Details

510(k) Number K173065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date April 24, 2019
Days to Decision 572 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
447d slower than avg
Panel avg: 125d · This submission: 572d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 281
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K173065.
Tel-O-Graph
K173895 · I.E.M. Industrielle Entwicklung and Medizintechnik · May 2019
Fully Automatic Electronic Blood Pressure Monitor
K183534 · Andon Health Co, Ltd. · May 2019
TOF-Cuff monitor
K181894 · Rgb Medical Devices SA · May 2019
HEM-6410T-ZL Wrist Blood Pressure Monitor
K190693 · Omron Healthcare, Inc. · Apr 2019
Transtek Blood Pressure Monitor
K181832 · Guangdong Transtek Medical Electronics Co., Ltd. · Apr 2019
GMC Upper Arm Automatic Blood Pressure Monitor
K181931 · Gmc, Inc. · Apr 2019